The New York City Economic Development Corporation's Early Stage Life Sciences Funding Initiative and venture funds partners, together with Celgene, General Electric Ventures, and Eli Lilly, committed a bare minimum of $100 million to assist start fifteen to twenty ventures in everyday living sciences and biotechnology. On December 19, 2011, Mayor Michael R.